Circulating tumor cells as a window on metastasis biology in lung cancer.
Krebs, Matthew G
Ward, Timothy H
Ranson, Malcolm R
Blackhall, Fiona H
AffiliationClinical and Experimental Pharmacology Group, University of Manchester, Manchester, United Kingdom.
MetadataShow full item record
AbstractCirculating tumor cell (CTC) number in metastatic cancer patients yields prognostic information consistent with enhanced cell migration and invasion via loss of adhesion, a feature of epithelial-to-mesenchymal transition (EMT). Tumor cells also invade via collective migration with maintained cell-cell contacts and consistent with this is the circulating tumor microemboli (CTM; contiguous groups of tumor cells) that are observed in metastatic cancer patients. Using a blood filtration approach, we examined markers of EMT (cytokeratins, E-cadherin, vimentin, neural cadherin) and prevalence of apoptosis in CTCs and CTM to explore likely mechanism(s) of invasion in lung cancer patients and address the hypothesis that cells within CTM have a survival advantage. Intra-patient and inter-patient heterogeneity was observed for EMT markers in CTCs and CTM. Vimentin was only expressed in some CTCs, but in the majority of cells within CTM; E-cadherin expression was lost, cytoplasmic or nuclear, and rarely expressed at the surface of the cells within CTM. A subpopulation of CTCs was apoptotic, but apoptosis was absent within CTM. This pilot study suggests that EMT is not prosecuted homogeneously in tumor cells within the circulation of lung cancer patients and that collective migration and enhanced survival of cells within CTM might contribute to lung cancer metastasis. Multiplex analysis and further detailed exploration of metastatic potential and EMT in CTCs/CTM is now warranted in a larger patient cohort.
CitationCirculating tumor cells as a window on metastasis biology in lung cancer. 2011, 178 (3):989-96 Am J Pathol
JournalThe American Journal of Pathology
- Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
- Authors: Krebs MG, Hou JM, Sloane R, Lancashire L, Priest L, Nonaka D, Ward TH, Backen A, Clack G, Hughes A, Ranson M, Blackhall FH, Dive C
- Issue date: 2012 Feb
- Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
- Authors: Hou JM, Krebs MG, Lancashire L, Sloane R, Backen A, Swain RK, Priest LJ, Greystoke A, Zhou C, Morris K, Ward T, Blackhall FH, Dive C
- Issue date: 2012 Feb 10
- Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
- Authors: Wu S, Liu S, Liu Z, Huang J, Pu X, Li J, Yang D, Deng H, Yang N, Xu J
- Issue date: 2015
- Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.
- Authors: Kallergi G, Papadaki MA, Politaki E, Mavroudis D, Georgoulias V, Agelaki S
- Issue date: 2011 Jun 10
- Prevalence and number of circulating tumour cells and microemboli at diagnosis of advanced NSCLC.
- Authors: Mascalchi M, Falchini M, Maddau C, Salvianti F, Nistri M, Bertelli E, Sali L, Zuccherelli S, Vella A, Matucci M, Voltolini L, Pegna AL, Luconi M, Pinzani P, Pazzagli M
- Issue date: 2016 Jan